• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用sFlt-1/PlGF比值诊断子痫前期和胎儿生长受限:全自动免疫分析系统Kryptor®的诊断准确性

Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.

作者信息

Dröge Lisa Antonia, Höller Alice, Ehrlich Laura, Verlohren Stefan, Henrich Wolfgang, Perschel Frank Holger

机构信息

Department of Obstetrics, Charité Universitätsmedizin Berlin, Germany.

Department of Obstetrics, Charité Universitätsmedizin Berlin, Germany.

出版信息

Pregnancy Hypertens. 2017 Apr;8:31-36. doi: 10.1016/j.preghy.2017.02.005. Epub 2017 Mar 1.

DOI:10.1016/j.preghy.2017.02.005
PMID:28501276
Abstract

OBJECTIVE

We aimed to characterize the diagnostic accuracy of the Kryptor® assay for sFlt-1 and PlGF in maternal serum samples of uneventful singleton pregnancies and subjects with preeclampsia (PE) and PE-related outcomes such as fetal growth restriction (FGR). Longitudinal reference ranges of the sFlt-1 and PlGF level in the course of normal pregnancies were generated.

METHODS

A cohort of subjects with PE and PE-related outcomes including FGR in the third trimester was compared to a cohort of women with uneventful outcome. Serum levels of sFlt-1, PlGF level as well as the sFlt-1/PlGF ratio was analysed with the Kryptor® assay and compared between the case- and control groups. Cut-off values were generated and diagnostic accuracy examined.

RESULTS

Longitudinal reference ranges of the sFlt-1 and PlGF level in healthy pregnancies were in line with those levels measured with other immunoassays. Comparison of the sFlt-1/PlGF ratio between PE-related outcomes including FGR or PE and healthy controls showed a high diagnostic accuracy with an area under the curve (AUC) of 0.917 for PE-related outcomes and 0.919 for PE.

摘要

目的

我们旨在评估Kryptor®检测法检测单胎妊娠结局正常的孕妇血清样本以及子痫前期(PE)患者血清样本中可溶性血管内皮生长因子受体-1(sFlt-1)和胎盘生长因子(PlGF)的诊断准确性,以及与PE相关的结局,如胎儿生长受限(FGR)。我们还生成了正常妊娠过程中sFlt-1和PlGF水平的纵向参考范围。

方法

将一组患有PE及包括孕晚期FGR在内的PE相关结局的受试者与一组妊娠结局正常的女性进行比较。采用Kryptor®检测法分析血清sFlt-1水平、PlGF水平以及sFlt-1/PlGF比值,并在病例组和对照组之间进行比较。确定临界值并检验诊断准确性。

结果

健康妊娠中sFlt-1和PlGF水平的纵向参考范围与其他免疫检测法测得的水平一致。PE相关结局(包括FGR或PE)与健康对照之间的sFlt-1/PlGF比值比较显示,诊断准确性较高,PE相关结局的曲线下面积(AUC)为0.917,PE的曲线下面积为0.919。

相似文献

1
Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.使用sFlt-1/PlGF比值诊断子痫前期和胎儿生长受限:全自动免疫分析系统Kryptor®的诊断准确性
Pregnancy Hypertens. 2017 Apr;8:31-36. doi: 10.1016/j.preghy.2017.02.005. Epub 2017 Mar 1.
2
Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.Kryptor 和 Elecsys® immunoassay sFlt-1/PlGF 比值与子痫前期和胎儿生长受限的早期诊断相关性:一项病例对照研究。
Pregnancy Hypertens. 2020 Apr;20:44-49. doi: 10.1016/j.preghy.2020.03.002. Epub 2020 Mar 3.
3
Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.应用可溶性血管内皮生长因子受体-1/胎盘生长因子比值识别子痫前期和胎儿生长受限的临床实践:一项前瞻性队列研究。
Pregnancy Hypertens. 2018 Jul;13:279-285. doi: 10.1016/j.preghy.2018.06.017. Epub 2018 Jun 30.
4
Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.妊娠32至37周时sFlt-1、PlGF、sFlt-1/PlGF比值及PAPP-A对晚发型子痫前期和胎儿生长受限的预测价值。
Pregnancy Hypertens. 2018 Apr;12:124-128. doi: 10.1016/j.preghy.2018.04.010. Epub 2018 Apr 11.
5
Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.血管生成因子、临床危险因素及子宫动脉多普勒超声对厄瓜多尔人群中孕中期及孕晚期子痫前期和胎儿生长受限的预测价值
J Matern Fetal Neonatal Med. 2016;29(4):537-43. doi: 10.3109/14767058.2015.1012063. Epub 2015 Feb 24.
6
Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.在伴有早发型胎儿生长受限的单胎妊娠中 sFlt-1/PlGF 比值的纵向变化。
Ultrasound Obstet Gynecol. 2018 Nov;52(5):631-638. doi: 10.1002/uog.18894.
7
The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.sFlt-1/PlGF 比值重复测量预测子痫前期和宫内生长受限的重要性。
J Perinat Med. 2014 Jan;42(1):61-8. doi: 10.1515/jpm-2013-0074.
8
Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?子痫前期和胎儿生长受限中的尿胎盘生长因子:循环生物标志物的替代物?
J Obstet Gynaecol Res. 2019 Sep;45(9):1828-1836. doi: 10.1111/jog.14038. Epub 2019 Jul 1.
9
Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.新型可溶性fms样酪氨酸激酶1和胎盘生长因子检测方法用于子痫前期诊断的分析评估
Clin Biochem. 2015 Nov;48(16-17):1113-9. doi: 10.1016/j.clinbiochem.2015.06.020. Epub 2015 Jun 27.
10
The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.可溶性血管内皮生长因子受体-1/胎盘生长因子比值对双胎妊娠短期子痫前期及母胎或新生儿并发症发生情况的预测价值。
Pregnancy Hypertens. 2018 Oct;14:222-227. doi: 10.1016/j.preghy.2018.03.014. Epub 2018 Mar 26.

引用本文的文献

1
Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.可疑子痫前期妇女中 Kryptor sFlt-1/PlGF 比值的决策阈值:常规临床环境中的回顾性研究。
J Am Heart Assoc. 2021 Sep 7;10(17):e021376. doi: 10.1161/JAHA.120.021376. Epub 2021 Aug 28.
2
Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.母体西地那非与安慰剂治疗严重早发型胎儿生长受限孕妇的随机临床试验。
JAMA Netw Open. 2020 Jun 1;3(6):e205323. doi: 10.1001/jamanetworkopen.2020.5323.
3
The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.
不对称二甲基精氨酸通过干扰血管内皮功能和血管生成在胎儿生长受限中的作用及机制。
J Assist Reprod Genet. 2020 May;37(5):1083-1095. doi: 10.1007/s10815-020-01750-5. Epub 2020 Mar 25.
4
Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia.血管生成因子失衡先于补体在 BPH/5 先兆子痫模型胎盘沉积。
FASEB J. 2018 May;32(5):2574-2586. doi: 10.1096/fj.201701008R. Epub 2018 Jan 8.